The Efficiency and Toxicity Of Anlotinib in Combination With Docetaxel Followed by Epirubicin and Cyclophosphamide Regimen as Neoadjuvant Treatment in IIB to IIIA Triple Negative Breast Cancer: A Single-Arm, Multicenter, Open-Label, Phase II Study
Titel:
The Efficiency and Toxicity Of Anlotinib in Combination With Docetaxel Followed by Epirubicin and Cyclophosphamide Regimen as Neoadjuvant Treatment in IIB to IIIA Triple Negative Breast Cancer: A Single-Arm, Multicenter, Open-Label, Phase II Study
Auteur:
Chen, Xi Wei, Xinyu Yao, Peizhuo Liu, Yanbin Guan, Haitao Kang, Huafeng Liu, Di Diao, Yan Ma, Xiaobin Min, Weili Shan, Changyou Zhao, Yang Zhao, Fang Chen, Yuanyuan Xiao, Dong She, Qing Liu, Youhuai Zhang, Yinbin Zhang, Shuqun